VRAX logo

Virax Biolabs Group Limited (VRAX) Depreciation And Amortization

Annual D&A

$103.10 K
+$103.10 K+100.00%

01 March 2024

VRAX Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VRAX Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+100.0%--
3 y3 years---
5 y5 years---

VRAX Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high
5 y5 yearsat high
alltimeall timeat high

Virax Biolabs Group Limited Depreciation And Amortization History

DateAnnualQuarterlyTTM
Mar 2024
$103.10 K(>+9900.0%)
-
-
DateAnnualQuarterlyTTM
Mar 2023
$0.00(0.0%)
-
-
Mar 2022
$0.00
-
-

FAQ

  • What is Virax Biolabs Group Limited annual depreciation & amortization?
  • What is the all time high annual D&A for Virax Biolabs Group Limited?
  • What is Virax Biolabs Group Limited annual D&A year-on-year change?

What is Virax Biolabs Group Limited annual depreciation & amortization?

The current annual D&A of VRAX is $103.10 K

What is the all time high annual D&A for Virax Biolabs Group Limited?

Virax Biolabs Group Limited all-time high annual depreciation & amortization is $103.10 K

What is Virax Biolabs Group Limited annual D&A year-on-year change?

Over the past year, VRAX annual depreciation & amortization has changed by +$103.10 K (+100.00%)